908 Devices Inc. MASS
Set alert
At close · Oct 30
After hours · Oct 30, 4:56 PM ET
- YTD
- +114.29%
- 1 year
- +47.44%
- Open
- 12.44
- Prev close
- 12.85
- Mkt cap
- 465.00M
- Vol
- 551.09K
- Avg vol
- 420.81K
- EPS
- -0.94
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.92
- High
- 12.60
- Forward P/E
- -1.78
- Beta
- 0.98
- Short ratio
- 3.57
- Inst. own
- 69.75%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 2.87
- 200-d avg
- 4.69
- 1y target
- 5.67
2Y chart
Events in this range
- Nov 12, 2024Earnings: -0.23; estimate -0.29; surprise 20.69%
- Nov 13, 2024Downgrade: Leerink Partners · Outperform → Market Perform
- Nov 13, 2024Rating: Stifel · Buy → Buy
Signals (103)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 30, 2026 | 2 days ago |
| MACD: Buy Signal | Oct 28, 2026 | 4 days ago |
| MACD: Sell Signal | Oct 8, 2026 | 3 weeks ago |
| RSI: Overbought | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| RSI: Overbought | Aug 27, 2026 | 2 months ago |
| RSI: Overbought | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 31, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 15, 2026 | 3 months ago |
| SMA: Bullish | Jul 14, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jul 9, 2026 | 3 months ago |
| SMA: Bearish | Jul 8, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 29, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 18, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 9, 2026 | 4 months ago |
| RSI: Overbought | May 28, 2026 | 5 months ago |
| MACD: Buy Signal | May 27, 2026 | 5 months ago |
| SMA: Bullish | May 19, 2026 | 5 months ago |
| SMA: Bearish | May 18, 2026 | 5 months ago |
| SMA: Bearish | May 18, 2026 | 5 months ago |
| MACD: Sell Signal | May 15, 2026 | 5 months ago |
| RSI: Overbought | May 8, 2026 | 5 months ago |
| MACD: Buy Signal | May 6, 2026 | 5 months ago |
| SMA: Bullish | May 5, 2026 | 6 months ago |
| SMA: Bullish | May 5, 2026 | 6 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 30, 2026 | 6 months ago |
| SMA: Bullish | Apr 30, 2026 | 6 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 23, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 6 months ago |
| SMA: Bullish | Apr 2, 2026 | 7 months ago |
| MACD: Buy Signal | Apr 2, 2026 | 7 months ago |
| SMA: Bearish | Mar 6, 2026 | 8 months ago |
| SMA: Bullish | Mar 4, 2026 | 8 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 2, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 26, 2026 | 8 months ago |
| SMA: Bullish | Feb 24, 2026 | 8 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 23, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 18, 2026 | 8 months ago |
| SMA: Bullish | Feb 17, 2026 | 8 months ago |
| SMA: Bearish | Feb 12, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 12, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Feb 6, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 5, 2026 | 8 months ago |
| SMA: Bearish | Jan 29, 2026 | 9 months ago |
| RSI: Overbought | Jan 22, 2026 | 9 months ago |
| SMA: Bullish | Jan 20, 2026 | 9 months ago |
| SMA: Bullish | Jan 20, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 6, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 17, 2025 | 10 months ago |
| SMA: Bearish | Dec 12, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 25, 2025 | 11 months ago |
| SMA: Bullish | Nov 21, 2025 | 11 months ago |
| SMA: Bearish | Nov 14, 2025 | 11 months ago |
| RSI: Oversold | Nov 11, 2025 | 11 months ago |
| SMA: Bearish | Nov 7, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 10, 2025 | 1 year ago |
| RSI: Overbought | Sep 22, 2025 | 1 year ago |
| SMA: Bullish | Sep 17, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 15, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Aug 15, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 14, 2025 | 1 year ago |
| SMA: Bullish | Aug 13, 2025 | 1 year ago |
| SMA: Bearish | Jul 31, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 30, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 23, 2025 | 1 year ago |
| RSI: Overbought | Jun 17, 2025 | 1 year ago |
| RSI: Overbought | Jun 10, 2025 | 1 year ago |
| RSI: Overbought | Jun 4, 2025 | 1 year ago |
| MACD: Buy Signal | May 28, 2025 | 1 year ago |
| SMA: Bullish | May 15, 2025 | 1 year ago |
| SMA: Bearish | May 14, 2025 | 1 year ago |
| MACD: Sell Signal | May 6, 2025 | 1 year ago |
| RSI: Overbought | Apr 22, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 16, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 26, 2025 | 1 year ago |
| SMA: Bullish | Mar 4, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 4, 2025 | 1 year ago |
| SMA: Bearish | Feb 26, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 25, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 14, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| SMA: Bearish | Feb 7, 2025 | 1 year ago |
| SMA: Bullish | Feb 5, 2025 | 1 year ago |
| SMA: Bearish | Feb 3, 2025 | 1 year ago |
| SMA: Bullish | Jan 30, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 30, 2025 | 1 year ago |
| SMA: Bearish | Jan 29, 2025 | 1 year ago |
| SMA: Bullish | Jan 15, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 26, 2024 | 1 year ago |
Key statistics
- Market cap
- 66.16M
- Enterprise value
- 7.23M
- Trailing P/E
- 0.00
- Forward P/E
- -1.78
- PEG ratio
- 0.00
- Price / sales
- 1.20
- Price / book
- 0.50
- EPS (TTM)
- -1.79
- Beta
- 0.98
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -109.11%
- Revenue (TTM)
- 55.16M
- Revenue growth
- 17.30%
- Free cash flow
- -18.16M
- Total cash
- 71.69M
- Total debt
- 7.18M
- Return on equity
- -40.00%
- Shares outstanding
- 34.82M
- Short % of float
- 6.31%
- 50-day average
- 2.87
- 200-day average
- 4.69
Analyst view
Consensus: none
- Target (low)
- 4.00
- Target (mean)
- 5.67
- Target (high)
- 7.00
- Strong buy0
- Buy4
- Hold1
- Sell0
- Strong sell0
Next earnings
Aug 6, 2024
Expected Aug 6, 2024. Consensus EPS estimate -0.365.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | -0.29 | -0.23 | +0.06 | +20.69% |
| Aug 6, 2024 | Jun 1, 2024 | -0.34 | -0.32 | +0.02 | +5.88% |
| Aug 6, 2024 | Jun 1, 2024 | -0.34 | — | — | — |
| Apr 30, 2024 | Mar 1, 2024 | -0.37 | -0.33 | +0.04 | +10.81% |
| Apr 30, 2024 | Mar 1, 2024 | -0.37 | — | — | — |
| Mar 5, 2024 | Dec 1, 2023 | -0.27 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 13, 2024 | Stifel | main | Buy | Buy |
| Nov 13, 2024 | Leerink Partners | down | Outperform | Market Perform |
| Oct 17, 2024 | Leerink Partners | main | Outperform | Outperform |
| May 13, 2024 | Stephens & Co. | reit | Overweight | Overweight |
| Sep 25, 2023 | Stephens & Co. | reit | Overweight | Overweight |
| Feb 7, 2023 | Stephens & Co. | init | — | Overweight |
About 908 Devices Inc.
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- 908devices.com
News
- Riverwater Micro Opportunities Strategy Q3 2026 Portfolio Activity
- 908 Devices to Report Third Quarter 2026 Financial Results on November 10, 2026
- Critical Contrast: TTM Technologies (NASDAQ:TTMI) versus 908 Devices (NASDAQ:MASS)
- 908 Devices (NASDAQ:MASS) Hits New 52-Week High – Here’s What Happened
- Masivo Silver Reports Broad Polymetallic Mineralization from Initial 2026 Drilling Program at Cerro Colorado Project, Sonora, Mexico
- Financial Analysis: IPG Photonics (NASDAQ:IPGP) vs. 908 Devices (NASDAQ:MASS)
- 908 Devices (NASDAQ:MASS) SVP Sells $53,726.54 in Stock
- Insider Selling: 908 Devices (NASDAQ:MASS) SVP Sells $216,343.89 in Stock
- 12 Information Technology Stocks Moving In Friday's After-Market Session
- Why Alaunos Therapeutics Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Your note
Sign in to keep a note on MASS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROWN CHRISTOPHER D | Officer | Conversion of Exercise of derivative security | Dec 18, 2024 | 946,453 |
| CRANDELL KEITH L. | Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Jun 11, 2024 | 5,738,970 |
| EISENBERG MARCIA | Director | Conversion of Exercise of derivative security | Jun 11, 2024 | 14,593 |
| ELOI FENEL M | Director | Conversion of Exercise of derivative security | Jun 11, 2024 | 15,450 |
| GEORGE JEFFREY P. | Director | Conversion of Exercise of derivative security | Jun 11, 2024 | 15,450 |
| GRIFFITH JOSEPH H. IV | Chief Financial Officer | Conversion of Exercise of derivative security | Mar 25, 2024 | 93,437 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK Investment Management, LLC | 9.25% | 3,219,549 | 6.12M | Sep 29, 2024 |
| Blackrock Inc. | 5.41% | 1,884,480 | 3.58M | Sep 29, 2024 |
| Vanguard Group Inc | 5.39% | 1,877,696 | 3.57M | Sep 29, 2024 |
| Ameriprise Financial, Inc. | 5.29% | 1,842,846 | 3.50M | Sep 29, 2024 |
| AWM Investment Company, Inc. | 4.52% | 1,574,330 | 2.99M | Sep 29, 2024 |
| Granahan Investment Management LLC | 2.47% | 861,433 | 1.64M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK ETF Tr-ARK Genomic Revolution ETF | 8.97% | 3,125,257 | 5.94M | Oct 30, 2024 |
| Columbia Fds Ser Tr I-Columbia Small Cap Growth Fd I | 4.33% | 1,508,606 | 2.87M | Aug 30, 2024 |
| Vanguard Total Stock Market Index Fund | 2.27% | 792,157 | 1.51M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.78% | 618,815 | 1.18M | Oct 30, 2024 |
| Vanguard Information Technology Index Fund | 1.74% | 605,983 | 1.15M | Aug 30, 2024 |
| Alger Fund-Small Cap Growth Fund | 1.28% | 444,981 | 845.46K | Jul 30, 2024 |